Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.

MLA

Pettersson, Filippa, et al. “Eukaryotic Translation Initiation Factor 4E as a Novel Therapeutic Target in Hematological Malignancies and Beyond.” Expert Opinion on Therapeutic Targets, vol. 18, no. 9, Sept. 2014, pp. 1035–48. EBSCOhost, https://doi.org/10.1517/14728222.2014.937426.

APA

Pettersson, F., Del Rincon, S. V., & Miller, W. H., Jr. (2014). Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond. Expert Opinion on Therapeutic Targets, 18(9), 1035–1048. https://doi.org/10.1517/14728222.2014.937426

Chicago

Pettersson, Filippa, Sonia V Del Rincon, and Wilson H Miller Jr. 2014. “Eukaryotic Translation Initiation Factor 4E as a Novel Therapeutic Target in Hematological Malignancies and Beyond.” Expert Opinion on Therapeutic Targets 18 (9): 1035–48. doi:10.1517/14728222.2014.937426.